For centuries, people have been searching for the secret of youthful skinan elixir that keeps skin radiant and healthy
In-home or on-location visits , whether at your home, hotel, or anywhere in South Florida
Spending acceleration increased from 34% annually during 2018-2022 to 62% between 2022-2023
Performance Pass members receive a complimentary Performance IV every month as part of their membership
Disponible en: Citado 14 de febrero de 2025
A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments